Sotera Health Co. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the 2025 Annual Meeting of Stockholders held by Sotera Health Company on May 21, 2025. The filing details the outcomes of three specific matters submitted to a vote by security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Stockholders approved the following three proposals:
- Election of Directors: All three Class II director nominees were elected to serve three-year terms until the 2028 annual meeting.
- Ruoxi Chen: 250,529,768 For; 24,438,535 Withheld.
- Karen A. Flynn: 268,380,572 For; 6,587,731 Withheld.
- Ann R. Klee: 245,999,274 For; 28,969,029 Withheld.
- Advisory Approval of Executive Compensation: The compensation of named executive officers was approved on a non-binding basis.
- For: 272,812,479
- Against: 1,865,802
- Abstain: 290,022
- Ratification of Independent Auditor: Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
- For: 275,831,763
- Against: 1,851
- Abstain: 46,537
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Confirmation that the three elected directors (Chen, Flynn, Klee) will serve until the 2028 annual meeting.
- Verification that Ernst & Young LLP is the appointed auditor for the fiscal year ending December 31, 2025.
- Review of the "Against" vote count for executive compensation (1,865,802) to assess shareholder sentiment on pay practices.